Valuation: Novartis AG

Market Cap 302B 259B 242B 222B 417B 28,832B 424B 2,851B 1,116B 14,460B 1,133B 1,108B 47,811B P/E 2026 *
22.4x
P/E 2027 * 19.4x
Enterprise Value 334B 287B 268B 246B 462B 31,956B 470B 3,160B 1,237B 16,027B 1,255B 1,228B 52,990B EV / Sales 2026 *
5.8x
EV / Sales 2027 * 5.37x
Free-Float
91.66%
Yield 2026 *
2.75%
Yield 2027 * 2.87%
1 day+0.02%
1 week+2.81%
Current month+0.49%
1 month+3.35%
3 months+7.32%
6 months+0.60%
Current year+16.08%
1 week 121.02
Extreme 121.02
128.26
1 month 121.02
Extreme 121.02
131.5
Current year 107.68
Extreme 107.68
131.5
1 year 96.03
Extreme 96.03
131.5
3 years 81.1
Extreme 81.1
131.5
5 years 72.84
Extreme 72.84
131.5
10 years 65.09
Extreme 65.09
131.5
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Compliance Officer 58 14/04/2025
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
2/17/26 A Sell 30,743 0.0015%
2/10/26 A Sell 7,500 0.0004%
2/9/26 A Sell 67,000 0.0032%
Change 5-day change 1-year change 3-year change Capi.($)
+0.02%+2.81%+24.29%+41.36% 302B
+4.46%+4.92%+82.07%+134.31% 1,141B
+0.85%+4.81%+53.77%+58.51% 659B
+2.72%+6.92%+28.99%+77.15% 470B
+0.72%+2.29%+41.23%+45.73% 366B
-0.59%+2.51%+0.22%+12.44% 254B
+4.02%+6.29%+49.67%+68.96% 239B
+0.39%+0.77%-13.04%-52.34% 207B
+2.90%+8.63%+25.11%+94.52% 183B
+3.63%+7.34%+11.53%-22.97% 161B
Average +0.80%+3.93%+30.39%+45.77% 398.19B
Weighted average by Cap. +0.45%+4.23%+45.41%+70.26%

Financials

2026 *2027 *
Net sales 57.65B 49.45B 46.18B 42.37B 79.67B 5,510B 80.98B 545B 213B 2,764B 216B 212B 9,137B 61.31B 52.59B 49.11B 45.06B 84.73B 5,860B 86.12B 579B 227B 2,939B 230B 225B 9,717B
Net income 13.95B 11.97B 11.17B 10.25B 19.28B 1,333B 19.6B 132B 51.63B 669B 52.38B 51.24B 2,211B 15.5B 13.3B 12.42B 11.39B 21.42B 1,482B 21.78B 147B 57.37B 743B 58.21B 56.94B 2,457B
Net Debt 32.68B 28.03B 26.18B 24.02B 45.16B 3,124B 45.91B 309B 121B 1,567B 123B 120B 5,180B 27.82B 23.86B 22.28B 20.44B 38.44B 2,659B 39.08B 263B 103B 1,334B 104B 102B 4,409B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
20/08/26 CHF 127.00 -0.09% 662,509
19/08/26 CHF 127.12 +1.24% 2,053,740
18/08/26 CHF 125.56 +1.75% 1,794,769
17/08/26 CHF 123.40 +0.78% 1,293,936
14/08/26 CHF 122.44 -1.05% 1,619,121
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
158.70USD
Average target price
154.23USD
Spread / Average Target
-2.82%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock